• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

14
3
2
2
1

COUNTRY

1
1
1

CATEGORIES

  • 13
  • 10
  • 5
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

14
18
25
39

PUBLISHED

0
1
7
39

PRODUCT TYPE

23
9
7

Search "Wyeth: Performance, Products, Pipeline and Potential" returned 39 results.

PRODUCT TITLE
Small Molecule Kinase Inhibitors - Global Strategic Business Report Small Molecule Kinase Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Small Molecule Kinase Inhibitors - Global Strategic Business Report

This report analyzes the Global Market for Small Molecule Kinase Inhibitors in Millions of US$ by the following Product Segments: Gleevec/Glivec, Tarceva, Sutent, Nexavar, Sprycel, Iressa, Tykerb/Tyverb,...

July 2009
FROM
The Global Pain Therapeutics Market, 4th Edition: Market Trends & R&D Insights The Global Pain Therapeutics Market, 4th Edition: Market Trends & R&D Insights - Product Thumbnail Image

The Global Pain Therapeutics Market, 4th Edition: Market Trends & R&D Insights

Pain continues to present numerous challenges to the biopharmaceutical industry According to the American Academy of Pain Medicine, over 76 million Americans suffer from pain Indeed, pain affects more...

October 2010
FROM
IMS Company Profiles:Wyeth IMS Company Profiles:Wyeth - Product Thumbnail Image

IMS Company Profiles:Wyeth

This Company Profile gives you the authoritative insight into a company at a strategic and local level Each individual profile analyzes the critical components that make up a pharmaceutical company,...

February 2009

Noven Pharmaceuticals, Inc. - Strategic SWOT Analysis Review

Noven Pharmaceuticals, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a...

February 2015
FROM
Ensuring Profitable Return-on-Investment (ROI) in Pharmaceutical Marketing: Using Analytics & Metrics to Improve the Bottom Line Ensuring Profitable Return-on-Investment (ROI) in Pharmaceutical Marketing: Using Analytics & Metrics to Improve the Bottom Line - Product Thumbnail Image

Ensuring Profitable Return-on-Investment (ROI) in Pharmaceutical Marketing: Using Analytics & Metrics to Improve the Bottom Line

This report explains the different methods being used such as ROI, promotional response models, econometrics and predictive algorithms and the pros and cons of the different approaches There are step-by-step...

June 2011

ImmunoGen, Inc. (IMGN) - Financial and Strategic SWOT Analysis Review

ImmunoGen, Inc. (IMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData...

January 2014
FROM

Pharmaceutical Products of the Future: 50-Company Pipeline Analysis to 2015

What Will The Pharmaceutical Market Look Like in the Next Five Years? In this report, Kalorama has analyzed the late stage R&D pipeline of the 50 top companies in pharmaceuticals -- the companies...

July 2010
FROM
Immtech Pharmaceuticals, Inc. (IMMP) - Financial and Strategic SWOT Analysis Review Immtech Pharmaceuticals, Inc. (IMMP) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Immtech Pharmaceuticals, Inc. (IMMP) - Financial and Strategic SWOT Analysis Review

Immtech Pharmaceuticals, Inc. (IMMP) - Financial and Strategic SWOT Analysis Review Summary Immtech Pharmaceuticals, Inc. (Immtech) is a pharmaceutical company that focuses on the global opportunities...

September 2012
FROM

Companion Biomarkers in Drug Development

Companion biomarkers are diagnostic tests that are specifically linked to a therapeutic drug either during its development or in the clinic This linkage can be an important component of the drug development...

August 2013
FROM

Anti-Infective Drugs Markets

Six infectious diseases -- pneumonia, tuberculosis, diarrheal diseases, malaria, measles and HIV/AIDS -- account for half of all premature deaths worldwide, killing mostly children and young adults,...

October 2010
FROM

Torisel (Renal Cell Carcinoma) - Analysis and Forecasts to 2022

Torisel (Renal Cell Carcinoma) - Analysis and Forecasts to 2022 Summary Our pharmaceuticals report, “Torisel (Renal Cell Carcinoma) - Analysis and Forecasts to 2022” provides Torisel sales forecasts...

March 2012
FROM
Crucell N.V. (CRXL) - Financial and Strategic SWOT Analysis Review Crucell N.V. (CRXL) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Crucell N.V. (CRXL) - Financial and Strategic SWOT Analysis Review

Crucell N.V. (CRXL) - Financial and Strategic SWOT Analysis Review Summary Crucell N.V. (Crucell) is a biopharmaceutical company engaged in developing, producing and marketing products for the treatment...

September 2011
FROM
US Cancer Pain Report US Cancer Pain Report - Product Thumbnail Image

US Cancer Pain Report

The US market for the drug treatment of cancer pain in 2008 is valued at $3 1 billion, according to US Cancer Pain Report The cancer pain market is dominated by opioid drugs, a trend expected to continue...

February 2009
FROM
Strategic Analysis of World Psychiatric Therapeutics Markets Strategic Analysis of World Psychiatric Therapeutics Markets - Product Thumbnail Image

Strategic Analysis of World Psychiatric Therapeutics Markets

Loss of Patent Protection Challenges Market Growth The imminent patent expiration for key anticonvulsants such as Neurontin (in 2004), Topamax (in 2004), and Trileptal (in 2005) is expected to create...

September 2004
FROM
Bionovo, Inc. (BNVI) - Financial and Strategic SWOT Analysis Review Bionovo, Inc. (BNVI) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Bionovo, Inc. (BNVI) - Financial and Strategic SWOT Analysis Review

Bionovo, Inc. (BNVI) - Financial and Strategic SWOT Analysis Review Summary Bionovo, Inc. (Bionovo) is a biopharmaceutical company that mainly focuses on the discovery and development of safe and...

September 2011
FROM
Amgen: Profile, Patents and Pipeline Amgen: Profile, Patents and Pipeline - Product Thumbnail Image

Amgen: Profile, Patents and Pipeline

Amgen is the world's largest biotechnology company and the eighth largest pharmaceutical company worldwide. Revenues have nearly doubled in the last three years, going from $5.52 billion in 2002 to...

September 2005
FROM
Dyslipidemia: Opportunities in Cardiovascular Risk Reduction Dyslipidemia: Opportunities in Cardiovascular Risk Reduction - Product Thumbnail Image

Dyslipidemia: Opportunities in Cardiovascular Risk Reduction

This report examines trends in the dyslipidemia market, which is poised for transformation with the advent of novel combination products and biopharmaceuticals Cholesterol (LDL and HDL) and triglycerides...

July 2008
Johnson & Johnson Strategic Analysis Profile Johnson & Johnson Strategic Analysis Profile - Product Thumbnail Image

Johnson & Johnson Strategic Analysis Profile

- The Johnson & Johnson Strategic Analysis Profile is a comprehensive profile of the company including both quantitative and qualitative research. The report examines the Johnson & Johnsons business...

February 2008
FROM
The Global Protein Therapeutics Market The Global Protein Therapeutics Market - Product Thumbnail Image

The Global Protein Therapeutics Market

The global protein therapeutics market was valued at US$57 billion in 2005 Biotechnology has made notable inroads in the field of protein therapeutics, resulting in some of the key products presently...

December 2006
FROM

Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024

Antibody drug conjugates (ADCs) are a new class of therapeutic agents, gaining increasing attention from both large and small pharmaceutical companies. Generally addressed as the marriage of an antibody...

August 2014
FROM
Loading Indicator

Our Clients

Intel Corporation Autodesk, Inc. Hewlett-Packard Company Ahlstrom Corporation SAP SE 3M Company Samsung Group Ltd.